The Centers for Disease Control and Prevention of the United States (CDC) listed Azerbaijan as one of the safest countries to travel to during the COVID-19 pandemic.
Azerbaijan was added to the “Level 1: Covid-19 Low” category by CDC on Monday.
According to the level’s criteria, a destination must have 49 or fewer new cases per 100,000 residents over the past 28 days to be named safe for traveling. In addition to Azerbaijan, CDC also included Libya and Armenia in the “Level 1: Covid-19 Low”.
“The drop was most impressive for Libya, which had been at high-risk Level 3. Armenia and Azerbaijan, both in the mountainous Caucasus region where Asia and Europe meet, had been at Level 2,” CNN Travel reported.
Destinations that have had more than 100 cases per 100,000 residents in the past 28 days have been added to the Level 3 “high risk” category, while “Level 2: Covid-19 Moderate” applies to those reporting 50 to 100 cases per 100,000 residents over the past four weeks.
According to the government data, 13 people contracted the novel virus on April 27. Currently, 132 active coronavirus patients are being treated in the country’s hospitals.
A total of 792,534 people have been infected in Azerbaijan since the pandemic started. The virus killed 9,708 over the same period.
Meanwhile, the government of Azerbaijan has been easing pandemic restrictions amidst the constant decrease in the number of infections. Starting on April 15, 2022, a negative PCR test result is no longer required for inbound travels. The mandatory requirement to wear a face mask indoors will also be canceled starting May 1, 2022.
Over 13.6 million vaccines against COVID-19 have been administered in Azerbaijan since mass vaccination started in January 2021. More than 4.8 million people have received two doses, while more than 3.2 million got a third or more. Those getting a “booster dose” after positive COVID-19 test results are over 238,000.
The vaccines offered in Azerbaijan include CoronaVac, Pfizer-BioNTech, Vaxzevria, and Sputnik V.